Clinical Trials
3 trialsNCT06950385 2026-05-22
SERENTA
Rapamycin Holdings Inc.
Phase 3 Recruiting
NCT03806426 2024-04-25
Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
S.L.A. Pharma AG
Phase 3 Unknown
NCT00339625 2020-05-15
Polyp Prevention Trial
National Institutes of Health Clinical Center (CC)
Phase 3 Completed